Toggle light / dark theme

Aug 29 (Reuters) — Britain’s state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three quarters.

Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England said on Tuesday hundreds of eligible patients treated with the immunotherapy, atezolizumab, were set to have “under the skin” injection, which will free up more time for cancer teams.

“This approval will not only allow us to deliver convenient and faster care for our patients, but will enable our teams to treat more patients throughout the day,” Dr Alexander Martin, a consultant oncologist at West Suffolk NHS Foundation Trust said.

Cancer has a powerful new enemy — and it is fueled by a 9-year-old girl with an unforgettable smile.

Researchers have developed a drug containing a molecule called AOH1996 that “appears to annihilate all solid tumors” in preclinical research — while leaving healthy cells unharmed.

The drug AOH1996 is named after Anna Olivia Healey, a cancer patient from Indiana who was born in 1996.

👉For business inquiries: [email protected].
✅ Instagram: https://www.instagram.com/pro_robots.

In the quest to overcome the limitations of the human body and mind, scientists worldwide are diligently working on various technologies. The question arises: What will human beings become after undergoing numerous enhancements? Will we retain our identity while embracing the possibilities offered by artificial intelligence? What extraordinary capabilities will biotechnology bestow upon us? And how will our emotions and desires evolve as our bodies undergo transformation?

Join us on a captivating journey to the year 2050, as we delve into the frontiers of scientific research, consult with visionary futurists, and examine the predictions of brilliant minds. Together, we will explore the profound changes that lie ahead!

00.00 — Introduction.

The central question in the ongoing hunt for dark matter is: what is it made of? One possible answer is that dark matter consists of particles known as axions. A team of astrophysicists, led by researchers from the universities of Amsterdam and Princeton, has now shown that if dark matter consists of axions, it may reveal itself in the form of a subtle additional glow coming from pulsating stars. Their work is published in the journal Physical Review Letters.

Dark matter may be the most sought-for constituent of our universe. Surprisingly, this mysterious form of matter, that physicist and astronomers so far have not been able to detect, is assumed to make up an enormous part of what is out there.

No less than 85% of matter in the universe is suspected to be “dark,” presently only noticeable through the gravitational pull it exerts on other astronomical objects. Understandably, scientists want more. They want to really see dark matter—or at the very least, detect its presence directly, not just infer it from gravitational effects. And, of course: they want to know what it is.

Japanese scientist Kikunae Ikeda first proposed umami as a basic taste—in addition to sweet, sour, salty and bitter—in the early 1900s. About eight decades later, the scientific community officially agreed with him.

Now, scientists led by researchers at the USC Dornsife College of Letters, Arts and Sciences have evidence of a sixth basic .

In research published in Nature Communications, USC Dornsife neuroscientist Emily Liman and her team found that the tongue responds to through the same that signals sour taste.

An international team of researchers has developed a new theoretical framework that bridges physics and biology to provide a unified approach for understanding how complexity and evolution emerge in nature.

This new work on “assembly ,” published today in Nature, represents a major advance in our fundamental comprehension of biological evolution and how it is governed by the physical laws of the universe. The paper is titled “Assembly Theory Explains and Quantifies Selection and Evolution.”

This research builds on the team’s previous work developing assembly theory as an empirically validated approach to life detection, with implications for the search for and efforts to evolve new life forms in the laboratory.